Cellumen, a drug discovery specialist based in Pittsburgh, has closed a Series B funding round, raising $8 million from Safeguard Scientifics
Cellumen, a drug discovery specialist based in Pittsburgh, has closed a Series B funding round, raising $8 million from Safeguard Scientifics
Copyright PEI Media
Not for publication, email or dissemination